Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Factors Associated With HSV PCR CSF Testing and Empiric Acyclovir Therapy in Young Febrile Infants.

Swartz S, Hadjiev J, Kolinski J, Chou E, Allen K, Yan K, Havens PL.

Clin Pediatr (Phila). 2019 Oct;58(11-12):1194-1200. doi: 10.1177/0009922819868687. Epub 2019 Aug 13.

PMID:
31409122
2.

Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.

Havens PL, Perumean-Chaney SE, Patki A, Cofield SS, Wilson CM, Liu N, Anderson PL, Landovitz RJ, Kapogiannis BG, Hosek SG, Mulligan K.

Clin Infect Dis. 2019 Jun 8. pii: ciz486. doi: 10.1093/cid/ciz486. [Epub ahead of print]

PMID:
31179503
3.

Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis.

Havens PL, Tamhane A, Stephensen CB, Schuster GU, Gordon CM, Liu N, Wilson CM, Hosek SG, Anderson PL, Kapogiannis BG, Mulligan K.

AIDS Res Hum Retroviruses. 2019 Feb;35(2):123-128. doi: 10.1089/AID.2018.0096. Epub 2018 Nov 5.

PMID:
30280906
4.

Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone.

Havens PL, Long D, Schuster GU, Gordon CM, Price G, Wilson CM, Kapogiannis BG, Mulligan K, Stephensen CB; Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 117 and 109 study teams.

Antivir Ther. 2018;23(7):623-628. doi: 10.3851/IMP3269. Epub 2018 Sep 27.

PMID:
30260797
5.

Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood.

Yang J, Nikanjam M, Best BM, Pinto J, Chadwick EG, Daar ES, Havens PL, Rakhmanina N, Capparelli EV.

J Clin Pharmacol. 2018 Dec;58(12):1604-1617. doi: 10.1002/jcph.1293. Epub 2018 Sep 25.

PMID:
30252146
6.

Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.

Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA 3rd, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K; Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team.

Clin Infect Dis. 2018 Jan 6;66(2):220-228. doi: 10.1093/cid/cix753.

7.

Low near infrared spectroscopic somatic oxygen saturation at admission is associated with need for lifesaving interventions among unplanned admissions to the pediatric intensive care unit.

Balakrishnan B, Dasgupta M, Gajewski K, Hoffmann RG, Simpson PM, Havens PL, Hanson SJ.

J Clin Monit Comput. 2018 Feb;32(1):89-96. doi: 10.1007/s10877-017-0007-1. Epub 2017 Mar 3.

PMID:
28258341
8.

Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.

Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N, Wilson CM, Hazra R, Hosek SG, Anderson PL, Seifert SM, Kapogiannis BG, Mulligan K; Adolescent Medicine Trials Network for HIV/AIDS Interventions 117 study team.

Clin Infect Dis. 2017 Feb 1;64(3):317-325. doi: 10.1093/cid/ciw765. Epub 2016 Nov 15.

9.

An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger than 2 Years Old.

Zembles TN, Thompson NE, Havens PL, Kaufman BA, Huppler AR.

Pharmacotherapy. 2016 Oct;36(10):1102-1108. doi: 10.1002/phar.1829. Epub 2016 Sep 20.

PMID:
27548272
10.

An Improved Indirect Procedure for Estimating Pesticide Volatility from Field Trials.

Cryer SA, Havens PL, Hillger DE, van Wesenbeeck IJ.

J Environ Qual. 2015 Sep;44(5):1513-22. doi: 10.2134/jeq2015.03.0125.

PMID:
26436268
11.

Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation.

Hanson SJ, Havens PL, Simpson PM, Nugent ML, Wells RG.

Pediatr Pulmonol. 2015 Dec;50(12):1328-35. doi: 10.1002/ppul.23184. Epub 2015 Apr 2.

PMID:
25847131
12.

Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy.

Havens PL, Hazra R.

Pediatr Infect Dis J. 2015 Apr;34(4):406-8. doi: 10.1097/INF.0000000000000650. No abstract available.

13.

Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*.

Schloemer NJ, Abu-Sultaneh S, Hanson SJ, Yan K, Hoffmann RG, Punzalan RC, Havens PL.

Pediatr Crit Care Med. 2014 Sep;15(7):e294-9. doi: 10.1097/PCC.0000000000000169.

PMID:
24901803
14.

Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.

Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K; Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 study team.

Antivir Ther. 2014;19(6):613-8. doi: 10.3851/IMP2755. Epub 2014 Feb 17.

15.

Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein.

Porter TR, Li X, Stephensen CB, Mulligan K, Rutledge B, Flynn PM, Lujan-Zilbermann J, Hazra R, Wilson CM, Havens PL, Tang J; Adolescent MedicineTrials Network for HIV/AIDS Interventions (ATN) 063 study team.

Front Genet. 2013 Nov 14;4:234. doi: 10.3389/fgene.2013.00234. eCollection 2013.

16.

Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?

Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K; Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 Study Team.

Antimicrob Agents Chemother. 2013 Nov;57(11):5619-28. doi: 10.1128/AAC.01096-13. Epub 2013 Sep 3.

17.

Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity.

Chiu YE, Havens PL, Siegel DH, Ali O, Wang T, Holland KE, Galbraith SS, Lyon VB, Drolet BA.

J Am Acad Dermatol. 2013 Jul;69(1):40-6. doi: 10.1016/j.jaad.2013.01.010. Epub 2013 Feb 14.

18.

Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection.

Havens PL, Mulligan K, Hazra R, Flynn P, Rutledge B, Van Loan MD, Lujan-Zilbermann J, Kapogiannis BG, Wilson CM, Stephensen CB; Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 Study Team.

J Clin Endocrinol Metab. 2012 Nov;97(11):4004-13. doi: 10.1210/jc.2012-2600. Epub 2012 Aug 29.

19.

Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma.

Hanson SJ, Punzalan RC, Arca MJ, Simpson P, Christensen MA, Hanson SK, Yan K, Braun K, Havens PL.

J Trauma Acute Care Surg. 2012 May;72(5):1292-7. doi: 10.1097/TA.0b013e31824964d1.

PMID:
22673257
20.

Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.

Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Mulligan K; Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions 063 study team.

Clin Infect Dis. 2012 Apr;54(7):1013-25. doi: 10.1093/cid/cir968. Epub 2012 Jan 19.

21.

Incidence and risk factors for venous thromboembolism in critically ill children with cardiac disease.

Hanson SJ, Punzalan RC, Christensen MA, Ghanayem NS, Kuhn EM, Havens PL.

Pediatr Cardiol. 2012 Jan;33(1):103-8. doi: 10.1007/s00246-011-0098-2. Epub 2011 Sep 7.

PMID:
21927987
22.

Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients.

Baheti G, Kiser JJ, Havens PL, Fletcher CV.

Antimicrob Agents Chemother. 2011 Nov;55(11):5294-9. doi: 10.1128/AAC.05317-11. Epub 2011 Sep 6.

23.

H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic.

Kumar S, Fan J, Melzer-Lange M, Trost J, Havens PL, Willoughby RE, Chusid MJ, Henrickson KJ.

Pediatr Emerg Care. 2011 Sep;27(9):804-7. doi: 10.1097/PEC.0b013e31822c125e.

PMID:
21878831
24.

Use of SOFEA to predict 1,3-D concentrations in air in high-use regions of California.

van Wesenbeeck IJ, Cryer SA, Havens PL, Houtman BA.

J Environ Qual. 2011 Sep-Oct;40(5):1462-9. doi: 10.2134/jeq2010.0132.

PMID:
21869508
25.

Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome.

Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, Peterson JM, Butani L, Jones DP, Havens PL, Patel HP, Wong CS, Andreoli SP, Rothbaum RJ, Beck AM, Tarr PI.

Arch Pediatr Adolesc Med. 2011 Oct;165(10):884-9. doi: 10.1001/archpediatrics.2011.152. Epub 2011 Jul 22.

26.

Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung.

Gupta S, Cogbill CH, Gheorghe G, Rao AR, Kumar S, Havens PL, Camitta BM, Warwick AB.

J Pediatr Hematol Oncol. 2011 Apr;33(3):e127-31. doi: 10.1097/MPH.0b013e3181faf89a.

PMID:
21399527
27.

Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI.

Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, Ledeboer NA, Simpson P, Vandyke M, Davis E, Gaffney K, Li SH, Bose ME, Henrickson KJ.

Viruses. 2010;2(4):782-795.

28.

Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection.

Kumar S, Havens PL, Chusid MJ, Willoughby RE Jr, Simpson P, Henrickson KJ.

Pediatr Infect Dis J. 2010 Jul;29(7):591-4.

PMID:
20589976
29.

Epstein-Barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent.

Gupta S, Havens PL, Southern JF, Firat SY, Jogal SS.

J Pediatr Hematol Oncol. 2010 May;32(4):e144-7. doi: 10.1097/MPH.0b013e3181c80bf3.

PMID:
20224440
30.

Incidence and risk factors for venous thromboembolism in critically ill children after trauma.

Hanson SJ, Punzalan RC, Greenup RA, Liu H, Sato TT, Havens PL.

J Trauma. 2010 Jan;68(1):52-6. doi: 10.1097/TA.0b013e3181a74652.

PMID:
20065757
31.

Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009.

Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, Ledeboer NA, Li SH, Henrickson KJ.

Viruses. 2009 Jun 1;1(1):72-83.

32.

Effect of volume resuscitation on regional perfusion in dehydrated pediatric patients as measured by two-site near-infrared spectroscopy.

Hanson SJ, Berens RJ, Havens PL, Kim MK, Hoffman GM.

Pediatr Emerg Care. 2009 Mar;25(3):150-3. doi: 10.1097/PEC.0b013e31819a7f60.

PMID:
19262423
33.

Evaluation and management of the infant exposed to HIV-1 in the United States.

Havens PL, Mofenson LM; American Academy of Pediatrics Committee on Pediatric AIDS.

Pediatrics. 2009 Jan;123(1):175-87. doi: 10.1542/peds.2008-3076. Review. Erratum in: Pediatrics. 2012 Dec;130(6):1183-4.

PMID:
19117880
34.

Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors.

Robbins BL, Capparelli EV, Chadwick EG, Yogev R, Serchuck L, Worrell C, Smith ME, Alvero C, Fenton T, Heckman B, Pelton SI, Aldrovandi G, Borkowsky W, Rodman J, Havens PL; PACTG 1038 Team.

Antimicrob Agents Chemother. 2008 Sep;52(9):3276-83. doi: 10.1128/AAC.00224-08. Epub 2008 Jul 14.

35.

Updated CDC guidelines for HIV testing: a review for Wisconsin practitioners.

Petroll AE, Galletly CL, Havens PL, Kwiecinski MF, Pinkerton SD.

WMJ. 2008 Apr;107(2):84-90. Review.

36.

Weight and health status of inner city African American children: Perceptions of children and their parents.

Skelton JA, Busey SL, Havens PL.

Body Image. 2006 Sep;3(3):289-93. Epub 2006 Jul 7.

PMID:
18089231
37.

Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.

Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR, Harris DR, Havens PL; Adolescent Trials Network for HIV/AIDS Interventions.

Antimicrob Agents Chemother. 2008 Feb;52(2):631-7. Epub 2007 Nov 19.

38.

Increasing antiretroviral drug access for children with HIV infection.

American Academy of Pediatrics Committee on Pediatric AIDS, Section on International Child Health, Havens PL, Gibb DM.

Pediatrics. 2007 Apr;119(4):838-45.

PMID:
17403860
39.

Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury.

Destino L, Sutton DA, Helon AL, Havens PL, Thometz JG, Willoughby RE Jr, Chusid MJ.

Ann Clin Microbiol Antimicrob. 2006 Sep 8;5:21.

40.

Assent for treatment: clinician knowledge, attitudes, and practice.

Lee KJ, Havens PL, Sato TT, Hoffman GM, Leuthner SR.

Pediatrics. 2006 Aug;118(2):723-30.

PMID:
16882829
41.

Nutrient deficiencies in tube-fed children.

Skelton JA, Havens PL, Werlin SL.

Clin Pediatr (Phila). 2006 Jan-Feb;45(1):37-41.

PMID:
16429214
42.

Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies.

Rao AR, Splaingard MS, Gershan WM, Havens PL, Thill A, Barbieri JT.

Pediatr Pulmonol. 2005 May;39(5):402-7.

PMID:
15666370
43.

Management of the infant born to a mother with HIV infection.

Havens PL, Waters D.

Pediatr Clin North Am. 2004 Aug;51(4):909-37, viii. Review.

PMID:
15275981
44.
45.

Intrapleural fibrinolysis for parapneumonic effusion and empyema in children.

Wells RG, Havens PL.

Radiology. 2003 Aug;228(2):370-8.

PMID:
12893898
46.

Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus.

Havens PL; American Academy of Pediatrics Committee on Pediatric AIDS.

Pediatrics. 2003 Jun;111(6 Pt 1):1475-89. Review.

PMID:
12777574
47.

The effectiveness of a follow-up program at improving HIV testing in a pediatric emergency department.

Beckmann KR, Melzer-Lange MD, Cuene B, Dietz M, Havens PL.

WMJ. 2002;101(8):30-4.

PMID:
12557610
48.

Validation of pesticide root zone model 3.12: employing uncertainty analysis.

Carbone JP, Havens PL, Warren-Hicks W.

Environ Toxicol Chem. 2002 Aug;21(8):1578-90.

PMID:
12152757
49.

Using Monte Carlo techniques to judge model prediction accuracy: validation of the pesticide root zone model 3.12.

Warren-Hicks W, Carbone JP, Havens PL.

Environ Toxicol Chem. 2002 Aug;21(8):1570-7.

PMID:
12152756

Supplemental Content

Loading ...
Support Center